6,047 followers
RT @BluefieldProj: (2/3) The Rademakers lab @MayoClinic reported that reducing TMEM106B levels in a mouse model of toxic gain-of-function C…
RT @BluefieldProj: (2/3) The Rademakers lab @MayoClinic reported that reducing TMEM106B levels in a mouse model of toxic gain-of-function C…
(2/3) The Rademakers lab @MayoClinic reported that reducing TMEM106B levels in a mouse model of toxic gain-of-function C9orf72-associated (GGGGCC)n expansions did not rescue behavioral or neuropathological phenotypes. https://t.co/iWDD5HyVNJ
Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9OR... https://t.co/rmSnJVJ2oQ